Director/PDMR Shareholding and Total Voting Rights
28 March 2024
Marlowe plc
Director/PDMR Shareholding
Total Voting Rights
Marlowe plc ("Marlowe", the "Group" or the "Company"), the UK leader in business-critical services and software which assure regulatory compliance, announces that on 27 March 2024, Kevin Quinn, Marlowe's Chairman, exercised 3,913 share options awarded pursuant to the Marlowe 2020 SAYE Scheme at an exercise price of 460 pence per new ordinary share (the "Exercise").
Following the allotment of the new ordinary shares of 50 pence each in the capital of the Company ("Ordinary Shares") to satisfy the Exercise, the Company's issued ordinary share capital will comprise 96,811,631 Ordinary Shares, none of which are held in treasury. Therefore, the total number of Ordinary Shares with voting rights in Marlowe following admission will be 96,811,631.
The above figure of 96,811,631 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.
The notification below, provided in accordance with the UK Market Abuse Regulation, provides further details.
For further information:
|
Marlowe plc |
||
|
Alex Dacre, Chief Executive |
www.marloweplc.com |
|
|
Adam Councell, Chief Financial Officer |
Tel: +44 (0) 203 813 8498 |
|
|
Benjamin Tucker, Head of Investor Relations |
|
|
|
|
|
|
|
|
|
|
|
Cavendish Capital Markets (Nominated Adviser and Joint Broker) |
||
|
Ben Jeynes |
Tel: +44 (0)20 7220 0500 |
|
|
George Lawson |
|
|
|
|
|
|
|
Berenberg (Joint Broker) |
||
|
Dan Gee-Summons |
Tel: +44 (0)20 3207 7800 |
|
|
Mark Whitmore |
|
|
|
|
|
|
|
Stifel (Joint Broker) |
||
|
Matthew Blawat |
Tel: +44 (0)20 7710 7688 |
|
|
Francis North |
|
|
|
|
|
|
|
FTI Consulting |
|
|
|
Nick Hasell |
Tel: +44 (0)20 3727 1340 |
|
|
Alex Le May |
|
|
About Marlowe plc
Marlowe is a UK leader in business-critical services and software which assure regulatory compliance. The company was formed to create sustainable shareholder value through the acquisition and development of businesses that provide regulated safety and compliance services and software. It is focused on compliance software, eLearning, health & safety, employment law & HR compliance, fire safety & security, water & air hygiene and occupational health services - all of which are vital to the wellbeing of its customers operations and are invariably governed by regulation. Marlowe currently provides software to over 1 million users and services to over 25% of Britain's commercial premises. The Group provides customers with a single outsourced, nationwide, provider of a range of regulated compliance and safety solutions. Our customers can be found in office complexes, high streets & leisure facilities, manufacturing plants and industrial estates, and include thousands of SMEs, local authorities, facilities management providers, multi-site NHS trusts and FTSE 100 companies.
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
||||
|
a) |
Name |
Kevin Quinn |
|||
|
2 |
Reason for the notification |
||||
|
a) |
Position/status |
Non-Executive Chairman |
|||
|
b) |
Initial notification /Amendment |
Initial notification |
|||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||
|
a) |
Name |
Marlowe plc |
|||
|
b) |
LEI |
213800ZWSR4SBOM6B608 |
|||
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||
|
a)
|
Description of the financial instrument, type of instrument |
Ordinary shares of 50 pence each |
|||
|
Identification code |
ISIN: GB00BD8SLV43 |
||||
|
b) |
Nature of the transaction |
Exercise of share options under the Marlowe 2020 SAYE Scheme
|
|||
|
c)
|
Price(s) and volume(s) |
|
|
|
|
|
|
|
Price(s) |
Volume(s) |
|
|
|
|
|
460 pence
|
3,913 |
|
|
|
|
|
|
|
|
|
|
d)
|
Aggregated information |
N/A single transaction |
|||
|
- Aggregated volume |
|
||||
|
- Price |
|
||||
|
e) |
Date of the transaction |
27 March 2024
|
|||
|
f) |
Place of the transaction |
Outside of a trading venue |
|||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 8 hours ago Luceco
- 8 hours ago Helios Towers
- 8 hours ago Wise Class A
- 9 hours ago EDX Medical Group Plc
- 9 hours ago Naked Wines